Novel Strategies for Granulocyte Colony-Stimulating Factor Treatment of Severe Prolonged Neutropenia Suggested by Mathematical Modeling
Open Access
- 15 October 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 14 (20), 6354-6363
- https://doi.org/10.1158/1078-0432.ccr-08-0807
Abstract
Purpose: To improve the effectiveness of granulocyte colony-stimulating factor (G-CSF) treatment in high-risk neutropenic patients.Keywords
Other Versions
This publication has 26 references indexed in Scilit:
- Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant ChemotherapyJNCI Journal of the National Cancer Institute, 2007
- Sustained G-CSF plasma levels following administration of pegfilgrastim fasten neutrophil reconstitution after high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myelomaExperimental Hematology, 2006
- 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice GuidelineJournal of Clinical Oncology, 2006
- Colony-Stimulating Factors for Chemotherapy-Induced Febrile Neutropenia: A Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Oncology, 2005
- Model Describing the Relationship Between Pharmacokinetics and Hematologic Toxicity of the Epirubicin-Docetaxel Regimen in Breast Cancer PatientsJournal of Clinical Oncology, 2005
- Chemotherapy‐induced neutropeniaCancer, 2004
- Structure and Function of Bone Marrow Hemopoiesis: Mechanisms of Response to Ionizing Radiation ExposureCancer Biotherapy & Radiopharmaceuticals, 2002
- Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3-Hour Infusion of PaclitaxelJapanese Journal of Cancer Research, 2001
- Endogenous haemopoietic growth factors in neutropenia and infectionBritish Journal of Haematology, 1994
- GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATIONThe Lancet, 1989